Discussion Paper: Biologic medicines and biosimilars in the Australian landscape – The challenges and the opportunities
1 August 2016
In Brief: Allens is engaging with stakeholders on the challenges and opportunities presented by biosimilars.
As part of this engagement, we highlight a number of key issues for discussion and comment.
- Ric MorganSpecial Counsel,
Ph: +61 3 9613 8425